<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00655980</url>
  </required_header>
  <id_info>
    <org_study_id>HSC 07-0592</org_study_id>
    <nct_id>NCT00655980</nct_id>
  </id_info>
  <brief_title>Vitamins in Nitrous Oxide Study</brief_title>
  <acronym>VINO</acronym>
  <official_title>Pharmacogenetics of Adverse Outcomes After Nitrous Oxide Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foundation for Anesthesia Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we want to find out if laughing gas (nitrous oxide) leads to a higher rate of&#xD;
      cardiac complications after surgery in patients with a specific genetic profile (mutations in&#xD;
      the MTHFR gene) and if this risk can be prevented by giving patients vitamin B12 and folate&#xD;
      during surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and significance: Recent studies have shown that nitrous oxide (N2O) anesthesia&#xD;
      may be associated with an increased risk of adverse cardiovascular outcomes. It is well-known&#xD;
      that N2O inhibits vitamin B12-dependent enzymes and as a result increases plasma homocysteine&#xD;
      concentrations. Homocysteine has been identified as risk factor for cardiovascular disease.&#xD;
      Therefore elevations in homocysteine after N2O may be a causative factor in N2O toxicity. In&#xD;
      a previous investigation, we found that patients who carry a homozygous mutation in the MTHFR&#xD;
      gene develop higher homocysteine levels after N2O anesthesia than non-carriers. These&#xD;
      patients might be at higher risk for adverse cardiac outcomes from N2O. Thus, there may be a&#xD;
      pharmacogenetic mechanism to account for the adverse cardiac outcomes from N2O. Moreover,&#xD;
      prevention of N2O-increased homocysteine concentrations in these high risk patients by&#xD;
      perioperative vitamin B12 and folate supplementation might decrease the incidence of adverse&#xD;
      cardiac outcomes.&#xD;
&#xD;
      Hypothesis: Patients carrying a homozygous MTHFR 677C&gt;T or 1298 A&gt;C variant allele will have&#xD;
      a higher incidence rate of postoperative myocardial ischemia after N2O anesthesia [detected&#xD;
      by serial TnI measurements] due to elevated homocysteine levels than normal &quot;wild-type&quot;&#xD;
      non-carriers, and that the incidence rate will be reduced if they receive perioperative&#xD;
      vitamin B12/folate supplementation.&#xD;
&#xD;
      Primary outcome: Myocardial ischemia in the first 72 hours after surgery (measured by serial&#xD;
      troponin and ECGs).&#xD;
&#xD;
      Secondary outcome: Composite endpoint of 30-day mortality and major cardiac morbidity&#xD;
      (non-fatal MI)&#xD;
&#xD;
      Design: Randomized controlled trial. 500 patients will receive N2O during surgery and will be&#xD;
      randomized to receive B-vitamins or placebo. 125 patients will receive no N2O and no&#xD;
      B-vitamins (control arm). Mendelian randomization of MTHFR genotype.&#xD;
&#xD;
      Intervention: IV vitamin B12 (1 mg) and folate (5 mg) pre- and postoperatively&#xD;
&#xD;
      Study setting: Barnes-Jewish-Hospital, St. Louis, MO&#xD;
&#xD;
      Patients: Patients scheduled for major surgery with or at risk for coronary artery disease&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial Ischemia</measure>
    <time_frame>first 3 postoperative days</time_frame>
    <description>Measured by serial troponin and ECG</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non-fatal MI</measure>
    <time_frame>30 day postoperative</time_frame>
    <description>Myocardial Infarction per Third Definition of MI</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">687</enrollment>
  <condition>Major Surgery</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin B12 and folic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Nitrous oxide and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin B12 and folic acid</intervention_name>
    <description>1 mg vitamin B12 IV 5 mg folic acid IV in 100 ml NS infusion</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitrous oxide and placebo</intervention_name>
    <arm_group_label>Comparator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard of care</intervention_name>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients; age &gt;18 yrs, ASA III-IV&#xD;
&#xD;
          -  Previously diagnosed coronary artery disease or at risk for coronary artery disease&#xD;
&#xD;
          -  Scheduled for major surgery (&gt;2 hrs)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not expected to live past 24 hours (ASA 5)&#xD;
&#xD;
          -  Patients with significant pulmonary disease requiring supplemental oxygen&#xD;
&#xD;
          -  Patients taking supplemental vitamin B12 or folate&#xD;
&#xD;
          -  Contraindication against N2O (pneumothorax, mechanical bowel obstruction, middle ear&#xD;
             occlusion, laparoscopic surgery, raised intracranial pressure)&#xD;
&#xD;
          -  Hypersensitivity to cobalamins&#xD;
&#xD;
          -  Leber's disease (hereditary optic nerve atrophy) [vitamin B12 interaction]&#xD;
&#xD;
          -  Seizure disorder [folate interference]&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Nagele, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 4, 2008</study_first_submitted>
  <study_first_submitted_qc>April 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2008</study_first_posted>
  <results_first_submitted>April 23, 2018</results_first_submitted>
  <results_first_submitted_qc>September 8, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 1, 2020</results_first_posted>
  <last_update_submitted>September 8, 2020</last_update_submitted>
  <last_update_submitted_qc>September 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>687 patients signed consent for enrollment; only 625 were analyzed.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Treatment</title>
          <description>Vitamin B12 and folic acid&#xD;
Vitamin B12 and folic acid: 1 mg vitamin B12 IV 5 mg folic acid IV in 100 ml NS infusion</description>
        </group>
        <group group_id="P2">
          <title>Comparator</title>
          <description>Nitrous oxide and placebo&#xD;
Nitrous oxide and placebo</description>
        </group>
        <group group_id="P3">
          <title>Standard of Care</title>
          <description>standard of care&#xD;
standard of care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="276"/>
                <participants group_id="P2" count="281"/>
                <participants group_id="P3" count="130"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="250"/>
                <participants group_id="P2" count="250"/>
                <participants group_id="P3" count="125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>surgery canceled; or subject or anesthes</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment</title>
          <description>Vitamin B12 and folic acid&#xD;
Vitamin B12 and folic acid: 1 mg vitamin B12 IV 5 mg folic acid IV in 100 ml NS infusion</description>
        </group>
        <group group_id="B2">
          <title>Comparator</title>
          <description>Nitrous oxide and placebo&#xD;
Nitrous oxide and placebo</description>
        </group>
        <group group_id="B3">
          <title>Standard of Care</title>
          <description>standard of care&#xD;
standard of care</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="250"/>
            <count group_id="B2" value="250"/>
            <count group_id="B3" value="125"/>
            <count group_id="B4" value="625"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.7" spread="10.6"/>
                    <measurement group_id="B2" value="65.2" spread="10.7"/>
                    <measurement group_id="B3" value="67.6" spread="10.9"/>
                    <measurement group_id="B4" value="65.5" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                    <measurement group_id="B2" value="97"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="234"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="158"/>
                    <measurement group_id="B2" value="153"/>
                    <measurement group_id="B3" value="80"/>
                    <measurement group_id="B4" value="391"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="250"/>
                    <measurement group_id="B2" value="250"/>
                    <measurement group_id="B3" value="125"/>
                    <measurement group_id="B4" value="625"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking history</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="195"/>
                    <measurement group_id="B2" value="175"/>
                    <measurement group_id="B3" value="94"/>
                    <measurement group_id="B4" value="464"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="200"/>
                    <measurement group_id="B2" value="204"/>
                    <measurement group_id="B3" value="100"/>
                    <measurement group_id="B4" value="504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic renal failute</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>on hemodialysis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Coronary artery disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                    <measurement group_id="B2" value="148"/>
                    <measurement group_id="B3" value="84"/>
                    <measurement group_id="B4" value="372"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Congestive heart failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peripheral vascular disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA staging</title>
          <description>ASA (American Society of Anesthesiologists) Physical status classification:&#xD;
ASA 1 = Normal healthy patient ASA 2 = Patient w/ mild systemic disease ASA 3 = Patient w/ severe systemic disease ASA 4 = Patient w/ severe systemic disease that is a constant threat to life ASA 5 = Moribund patient who's not expected to survive without the operation ASA 6 = Declared brain-dead patient, organs are being removed for donor purposes&#xD;
Higher values reflect worse disease status.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ASA 1-A normal healthy patient</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 2 A patient with mild systemic disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 3 - A patient with severe systemic disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="199"/>
                    <measurement group_id="B2" value="196"/>
                    <measurement group_id="B3" value="106"/>
                    <measurement group_id="B4" value="501"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 4 -A patient with severe systemic disease tha</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lee's revised cardiac risk index (Mean</title>
          <description>Lee's Revised Cardiac Risk Index Rapid pre-op assessment using the Revised Cardiac Risk Index&#xD;
Patients receive 1 point for meeting a criteria; then totaled to get their prospective risk level.&#xD;
High risk surgery Having Coronary Artery Disease Having Congestive Heart Failure Having Cerebrovascular Disease Having Diabetes Mellitus and on insulin Having a Serum Creatinine &gt;2 mg/dl or &gt;177 Î¼mol/L&#xD;
Higher totals connote higher risk (range 0-6)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.9" spread="0.8"/>
                    <measurement group_id="B2" value="2.0" spread="0.9"/>
                    <measurement group_id="B3" value="2.1" spread="0.8"/>
                    <measurement group_id="B4" value="2.0" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Plasma total homocysteine mol/L</title>
          <units>mcmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.5" spread="5.7"/>
                    <measurement group_id="B2" value="13.4" spread="5.8"/>
                    <measurement group_id="B3" value="11.6" spread="4.2"/>
                    <measurement group_id="B4" value="13.1" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>MTHFR C677T polymorphism</title>
          <description>The MTHFR C677T polymorphism reduces MTHFR enzyme activity; therefore, these patients have higher risk factors for coronary artery disease, acute myocardial infarction, peripheral vascular artery disease, stroke, or venous thromboembolism; having increased basal homocysteine levels or an abnormal methionine-load test (e.g., deficiency of vitamins B12, B6, and folic acid).</description>
          <population>Some patients had missing genotype</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="242"/>
                    <count group_id="B2" value="245"/>
                    <count group_id="B3" value="102"/>
                    <count group_id="B4" value="589"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>677CC</title>
                  <measurement_list>
                    <measurement group_id="B1" value="137"/>
                    <measurement group_id="B2" value="130"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="324"/>
                  </measurement_list>
                </category>
                <category>
                  <title>677CT</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="202"/>
                  </measurement_list>
                </category>
                <category>
                  <title>677TT</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>MTHFR A1298C plymorphism</title>
          <description>The MTHFR A1298C polymorphism reduces MTHFR enzyme activity; therefore, these patients have higher risk factors for coronary artery disease, acute myocardial infarction, peripheral vascular artery disease, stroke, or venous thromboembolism; having increased basal homocysteine levels or an abnormal methionine-load test (e.g., deficiency of vitamins B12, B6, and folic acid).</description>
          <population>Some patients had missing genotypes</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="243"/>
                    <count group_id="B2" value="244"/>
                    <count group_id="B3" value="102"/>
                    <count group_id="B4" value="589"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>1298AA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="133"/>
                    <measurement group_id="B2" value="120"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="303"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1298AC</title>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="236"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1298CC</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medications Aspirin</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="137"/>
                    <measurement group_id="B3" value="69"/>
                    <measurement group_id="B4" value="332"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medications Clopidogrel</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medications Warfarin</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medications Beta-Blocker</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="141"/>
                    <measurement group_id="B3" value="70"/>
                    <measurement group_id="B4" value="330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ACE-Inhibitor</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Statin</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="69"/>
                    <measurement group_id="B4" value="345"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diuretic</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="87"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical procedure Vascular</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="87"/>
                    <measurement group_id="B3" value="53"/>
                    <measurement group_id="B4" value="216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical procedure Orthopedic</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="88"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical procedure ENT</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical procedure gyn</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical procedure Urology</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="250"/>
                    <count group_id="B2" value="250"/>
                    <count group_id="B3" value="125"/>
                    <count group_id="B4" value="625"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Myocardial Ischemia</title>
        <description>Measured by serial troponin and ECG</description>
        <time_frame>first 3 postoperative days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>B-Vitamin Group</title>
            <description>Vitamin B12 and folic acid&#xD;
Vitamin B12 and folic acid: 1 mg vitamin B12 IV 5 mg folic acid IV in 100 ml NS infusion</description>
          </group>
          <group group_id="O2">
            <title>Comparator</title>
            <description>Nitrous oxide and placebo&#xD;
Nitrous oxide and placebo</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care</title>
            <description>Patients did neither receive nitrous oxide nor B-vitmamins</description>
          </group>
        </group_list>
        <measure>
          <title>Myocardial Ischemia</title>
          <description>Measured by serial troponin and ECG</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="250"/>
                <count group_id="O2" value="250"/>
                <count group_id="O3" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Cardiac troponin elevation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Cardiac troponin elevation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="217"/>
                    <measurement group_id="O2" value="216"/>
                    <measurement group_id="O3" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non-fatal MI</title>
        <description>Myocardial Infarction per Third Definition of MI</description>
        <time_frame>30 day postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>B-Vitamin Group</title>
            <description>Vitamin B12 and folic acid</description>
          </group>
          <group group_id="O2">
            <title>Comparator</title>
            <description>Nitrous oxide and placebo</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care</title>
            <description>No nitrous oxide No B-vitamins</description>
          </group>
        </group_list>
        <measure>
          <title>Non-fatal MI</title>
          <description>Myocardial Infarction per Third Definition of MI</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="250"/>
                <count group_id="O2" value="250"/>
                <count group_id="O3" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 day</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment</title>
          <description>Vitamin B12 and folic acid&#xD;
Vitamin B12 and folic acid: 1 mg vitamin B12 IV 5 mg folic acid IV in 100 ml NS infusion</description>
        </group>
        <group group_id="E2">
          <title>Comparator</title>
          <description>Nitrous oxide and placebo&#xD;
Nitrous oxide and placebo</description>
        </group>
        <group group_id="E3">
          <title>Standard of Care</title>
          <description>standard of care&#xD;
standard of care</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="61" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Readmission</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Any Pulmonary</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Principal Investigator</name_or_title>
      <organization>University of Chicago Medicine</organization>
      <phone>7737022544</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

